Crinetics Pharmaceuticals, Inc.
Formulations of a somatostatin modulator
Last updated:
Abstract:
Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
Status:
Grant
Type:
Utility
Filling date:
7 Sep 2021
Issue date:
8 Mar 2022